Mr Vikas Sinha, Dr David Ebsworth, Dr Andrew Sinclair
Download Audit Committee terms of reference
Dr Ken Cunningham, Dr David Ebsworth, Mr Rishi Gupta
Download Remuneration Committee terms of reference
Dr David Ebsworth, Dr Mahendra Shah, Dr Anders Ullman
Download Nominations Committee terms of reference
The Board of Directors of Verona Pharma recognises the importance of sound corporate governance and strives, where practicable for a company of its size and nature, to comply with the standards of good practice prescribed by the UK Corporate Governance Code (2012) in its four specified areas:
For a copy of the UK Corporate Governance Code (2012), visit the UK Financial Reporting Council (FRC) website at www.frc.org.uk
The Board of Directors has established an Audit Committee, a Remuneration Committee and a Nominations and Corporate Governance Committee, with formally delegated duties and responsibilities
The Company has adopted a share dealing code in order to ensure compliance with the EU Market Abuse Regulation and Rule 21 of the AIM Rules.
The Company has adopted a code of business conduct and ethics in order to ensure compliance with the UK Bribery Act (2010) and as the Company’s “code of ethics” within the meaning of the Sarbanes-Oxley Act (2002).
The Company has adopted an AIM Rules compliance policy in order to ensure compliance with Rule 31 of the AIM Rules.
The Company has adopted policies and procedures for complaints regarding accounting, internal accounting controls, fraud and auditing matters. The Board has appointed a "compliance officer" to oversee compliance with the policies and procedures.
Verona Pharma is an organization with strong values of responsibility and integrity. Our Code of Business Conduct and Ethics contains general guidelines for conducting business with the highest standards of ethics.
Verona Pharma is committed to an environment where open, honest communications are the expectation, not the exception. We want you to feel comfortable in approaching your supervisor or management in instances where you believe violations of policies or standards have occurred.
In situations where you prefer to place an anonymous report in confidence, you are encouraged to use this hotline, hosted by a third party hotline provider, EthicsPoint. You are encouraged to submit reports relating to violations stated in our Code of Business Conduct and Ethics as well as our Policies and Procedures for Complaints regarding Accounting, Internal Accounting Controls, Fraud or Auditing Matters.
The information you provide will be sent to us by EthicsPoint on a totally confidential and anonymous basis if you should choose. You have our guarantee that your comments will be heard.
See the EthicsPoint FAQs for more information.
To make a report please go to the EthicsPoint website here where you will be able to find the appropriate information for filing a report. Please note, EthicsPoint is NOT a 911 or Emergency Service. Do not use the EthicsPoint website to report events presenting an immediate threat to life or property. Reports submitted through this service may not receive an immediate response. If you require emergency assistance, please contact your local authorities.
The next General Meeting of shareholders of the Company is scheduled to be held on June 26, 2018 at 4:00 p.m. at the offices of Latham & Watkins (London) LLP, 99 Bishopsgate, London, EC2M 3XF, United Kingdom. The Circular incorporating the notice convening the General Meeting and related documentation can be found below: